Obesity And Health

No suicidal thoughts link to diabetes, obesity drugs, finds UK regulator

The Medicines and Healthcare products Regulatory Agency (MHRA) began a review of safety data for the class of drugs, known as GLP-1 receptor agonists, more than a year ago

Waist-to-height ratio more effective than BMI for obesity diagnosis: Study

Obesity can no longer be just defined by body mass index (BMI) and rather should be about how body fat is distributed throughout one's body, researchers said while launching a new framework for diagnosing and managing obesity. Published in the journal Nature Medicine, the framework looks specifically at fat accumulated in the abdomen, measured as 'waist-to-height ratio' -- an increased value of which is related to a higher risk of developing cardiometabolic complications, according to the researchers. An "important novelty" of the framework is including a waist-to-height ratio higher than 0.5, along with a BMI of 25-30, for diagnosing obesity, the authors, representing the European Association for the Study of Obesity (EASO), said. "The choice of introducing waist-to-height ratio, instead of waist circumference, in the diagnostic process is due to its superiority as a cardiometabolic disease risk marker," they wrote. Accumulation of abdominal fat is a more reliable predictor of hea

New oral diabetes and obesity drug sale doubles in India amid demand surge

The sales of Novo Nordisk's Rybelsus tablet, used for diabetes treatment and weight reduction, more than doubled to Rs 363 crore this year from Rs 147 crore last year

Biocon leads India's push into anti-obesity drugs as patents lapse

The company, helmed by Kiran Mazumdar Shaw, is leading the charge among Indian drugmakers - the world's largest supplier of generic medicines - as they race to grab a slice of the obesity drugs market

Obesity drugs will not solve our billion-person problem, warns WHO

New obesity drugs such as Novo Nordisk A/S's Wegovy and Eli Lilly & Co.'s Zepbound could be an $80 billion market by 2030

Around 12.5 mn children in India aged between 5-19 are obese: Report

About 12.5 million children aged between five and 19 in India were overweight in 2022, according to a global analysis published in The Lancet journal Of the 12.5, 7.3 million were boys and 5.2 million girls. The total number of children, adolescents and adults worldwide living with obesity has surpassed one billion. These trends, together with the declining prevalence of people underweight since 1990, make obesity the most common form of malnutrition in most countries, the researchers said. Obesity and underweight are both forms of malnutrition and are detrimental to people's health in many ways. The latest study provides a highly detailed picture of global trends in both forms of malnutrition over the last 33 years. The analysis by the NCD Risk Factor Collaboration (NCD-RisC) -- a global network of scientists -- and the World Health Organization (WHO) estimates that the rate of obesity among the world's children and adolescents in 2022 was four times the rate in 1990. It is very

12.5 mn children, teens in India obese in 2022, shows Lancet study

About 12.5 million children aged between five and 19 in India were overweight in 2022, according to a global analysis published in The Lancet journal Of the 12.5, 7.3 million were boys and 5.2 million girls. The total number of children, adolescents and adults worldwide living with obesity has surpassed one billion. These trends, together with the declining prevalence of people who are underweight since 1990, make obesity the most common form of malnutrition in most countries, the researchers said. Obesity and underweight are both forms of malnutrition and are detrimental to people's health in many ways. The latest study provides a highly detailed picture of global trends in both forms of malnutrition over the last 33 years. The analysis by the NCD Risk Factor Collaboration (NCD-RisC) -- a global network of scientists -- and the World Health Organization (WHO) estimates that among the world's children and adolescents, the rate of obesity in 2022 was four times the rate in 1990. It

Eli Lilly expects to launch obesity drug in India next year, says CEO

Mounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both conditions

Incisionless device could revolutionise treatment for metabolic diseases

A completely incisionless device that replicates metabolic surgery without making any cuts could surpass current technologies for managing conditions such as severe obesity and type 2 diabetes, a team led by an Indian researcher has found. The ForePass device could provide unmatched treatment for millions of people who reject invasive surgery or do not respond to drugs, the researchers said. The study led by Manoel Galvao Neto, from Sri Aurobindo Medical College in Madhya Pradesh, found that the ForePass endoscopic showed extraordinary efficacy in treating conditions such as severe obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH). Results, published in the journal Gut, revealed a 79 per cent reduction in weight gain compared to the control group, suggesting it may be substantially more effective than common metabolic surgeries like gastric bypass. The study also showed substantial improvements in how the body handles insulin and reduces glucose

Eli Lilly's Mounjaro gives positive results in obese diabetic people

Diabetes occurs when the body loses the ability to control blood sugar, and it's one of the world's most common serious diseases

Covid vax, booster dose immunity to decline rapidly in obese people: Study

A modest increase in risk was also seen in people with obesity (30-39.9kg/m2), and those who were underweight

British court rejects Kellogg's arguments against new sugar rules

Breakfast food giant Kellogg Co. lost a legal bid on Monday to block new anti-obesity measures in England banning the promotion of sugary cereals. The US company that makes Coco Pops, Frosted Flakes, Frosties and Rice Krispies had challenged the UK government over regulations taking effect in October restricting the promotion of foods high in fat, sugar or salt. A High Court judge rejected the company's argument that the regulations don't take into account the nutritional value of milk added to cereal. Judge Thomas Linden said that mixing a breakfast cereal that's high in sugar with milk does not change the fact that it's high in sugar. Kellogg's argument that its cereals like Crunchy Nut Clusters and Milk Chocolate Curls somehow become healthy products if they are consumed with milk is wholly unconvincing, as the addition of milk does not alter the nutritional profile of the products themselves," the judge wrote. Under the regulations, unhealthy foods will be banned from high-pro

Nearly one-fourth of all men and women in India are now obese: NFHS

NFHS notes steady increase in obesity among women as household wealth increases

How keeping a check on weight can help you avoid knee-related issues

Tips for healthy joints

Avoid obesity, maintain healthy lifestyle to lower risk of knee replacement

A balanced diet can help in maintaining good metabolism in the body in patients with obesity, diabetes, and cardiac illness

'Fat but fit'? The controversy continues

A new study says that obese people are still more likely to develop heart disease than their peers who aren't overweight